Results 81 to 90 of about 236 (123)

Mandatory Requirements for Planning and Commissioning of Medical Cyclotron Facility. [PDF]

Indian J Nucl Med
Kumar R, Tandon P, Deep K.
europepmc   +1 more source

Potential Application of Ionic Liquids for Electrodeposition of the Material Targets for Production of Diagnostic Radioisotopes. [PDF]

Materials (Basel), 2020
Chotkowski M, Połomski D, Czerwinski K.
europepmc   +1 more source

In-target production of [¹¹C]CH₄ from a nitrogen/hydrogen gas target as a function of beam current, irradiation time, and target temperature. [PDF]

EJNMMI Radiopharm Chem
Helin S, Rajander J, Aromaa J, Arponen E, Helin JS, Solin O.   +5 more
europepmc   +1 more source

Sustainable production of radionuclidically pure antimony-119. [PDF]

EJNMMI Radiopharm Chem
Olson AP, Verich FA, Ellison PA, Aluicio-Sarduy E, Nickles RJ, Mixdorf JC, Barnhart TE, Engle JW.   +7 more
europepmc   +1 more source

Synthesis of DOTA-Based ⁴³Sc Radiopharmaceuticals Using Cyclotron-Produced ⁴³Sc as Exemplified by [⁴³Sc]Sc-PSMA-617 for PSMA PET Imaging. [PDF]

Methods Protoc
Meier JP, Bhuiyan M, Freifelder R, Zhang HJ, Gonzalez L, Pusateri A, Tsai HM, Leoni L, Ghosh K, Markiewicz E, Henning C, Zhang Y, Weichselbaum R, Nolen J, Rotsch DA, Kao CM, Szmulewitz RZ, Chen CT, Chitneni SK.   +18 more
europepmc   +1 more source

Rapid fabrication and dissolution of pressed ⁵⁸Ni/Mg matrix targets for ⁵⁵Co production. [PDF]

EJNMMI Radiopharm Chem
Siikanen J, Siikanen J, Milton S, Bratteby K, Lin W, Engle JW, Jussing E, Tran TA.   +7 more
europepmc   +1 more source

Production of the PET radionuclide ⁶¹Cu via the ⁶²Ni(p,2n)⁶¹Cu nuclear reaction. [PDF]

EJNMMI Radiopharm Chem
Brühlmann SA, Walther M, Kopka K, Kreller M.   +3 more
europepmc   +1 more source

High yield cyclotron production of a novel ^133/135La theranostic pair for nuclear medicine. [PDF]

Sci Rep, 2020
Nelson BJB, Wilson J, Andersson JD, Wuest F.   +3 more
europepmc   +1 more source

Scalability study on [¹³³La]LaCl₃ production with a focus on potential clinical applications. [PDF]

EJNMMI Radiopharm Chem
Brühlmann SA, Walther M, Blei MK, Mamat C, Kopka K, Freudenberg R, Kreller M.   +6 more
europepmc   +1 more source